Press Releases

We spoke with Karl Hofmann, president and CEO of Population Services International (PSI), to hear about his time serving as

NEW YORK, HERTFORDSHIRE, England and PITTSBURGH – April 18, 2019 – Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan

March 20, 2019 – Building a Tuberculosis Free World: The Lancet Commission on Tuberculosis, released today, outlines what is needed

NEW YORK, NY (March 8, 2019)—TB Alliance’s new drug application (NDA) for the novel tuberculosis (TB) drug candidate pretomanid has

NEW YORK (February 5, 2019) – TB Alliance applauds the Wellcome Trust’s commitment of over £10 million to the Drugs

Please note: this article discusses a major plot point of Red Dead Redemption 2 For players of Red Dead Redemption

NEW YORK (January 15, 2019)—TB Alliance, a not-for-profit organization dedicated to developing new drug regimens to fight tuberculosis (TB), has

December 4, 2018 – NEW YORK – Though global funding for tuberculosis (TB) research is beginning to move in the

[November 28, 2018, WASHINGTON, D.C.] – TB Alliance and partners were honored today as the winner of the Global Health

Project Syndicate Op-Ed by Willo Brock, SVP External Affairs, TB Alliance NEW YORK – In the 25 years since tuberculosis